Webinars

Every month, Excellis offers free webinars on DSCSA and the healthcare and pharmaceutical industries.


Upcoming Webinar

Tuesday, June 7 @ 11:30AM EDT (8:30AM PDT)
“Quality & Regulatory Webinar: Quality Advice for Virtual Pharmas”
Join us for a webinar that features best-practice advice for virtual pharmas on the timely adoption of quality and document management systems to mitigate risk and facilitate successful launches, including topics such as:

  • Is your team adopting the best approach or just imitating what worked in the past for big pharma?
  • How do you extend your Quality systems/processes to external partners?
  • When is the optimal time to adopt a formal QMS/DMS solution as you approach launch?

Have the opportunity to WIN a $100 Amazon gift card by registering and attending!

Panelists include:

  • Jeff Ketelhut, CIO, Atara Biotherapeutics
  • Greg Cathcart, CEO, Excellis
  • Jose Sifontes, President of Quality & Regulatory, Excellis

Register Today!


Past Webinars

April 17, 2018: DSCSA Update, OIG March 2018 Dispenser Report, and FDA Guidances

  • DSCSA regulation update, timelines and operational implications
  • Office of Inspector General (OIG) March 2018 Report
  • Federal Drug Administration 2 new guidances

View a Copy of the Recording


February 27, 2018: DSCSA Update & Learn the 5 key elements to ensure a great solution selection

Purchasing or replacing a Track and Trace DSCSA Technology Solution? Learn the 5 key elements to ensure a great selection in meeting your organization’s needs. Learn About…

  • DSCSA regulation update & timelines for consideration in selecting a technology solution
  • Compliance and operational value – can both be achieved with a technology solution?
  • Key elements in comparing and selecting a technology solution
  • Considerations of pharmacy manufacturers serializing product by 11/2018
  • Advantages for the pharmacy supply chain
  • Why are so many organizations considering changing solution vendors?

View a Copy of the Recording


December 19, 2017: DSCSA Track and Trace: Achieving Compliance and Improved Medication & Patient Safety

  • Key Elements to ensure compliance and improve medication & patient safety
  • Implications and Opportunities of the November 2017 electronic lot traceability date
  • FDA’s 11/27/2017 guidance regarding grandfathering product & implications for healthcare and retail

View a Copy of the Recording


November 7, 2017: OIG & FDA Latest Report and Impacts to Health Systems
OIG and FDA latest report/guidance & Are you prepared for Electronic Lot Traceability November 2017 Deadline Impact

  • What are the implications of Wholesalers exchanging drug product tracing information using a wide variety of transmission modes and formats?
  • Are direct purchase statements accurate with the required information?
  • How is the determination of DSCSA exempt and non-exempt products? How trading partners might resolve/prevent disagreements?
  • 340B pharmacies: What is the latest guidance regarding the exchange of drug product tracing information for sales to 340B-covered entities that use 340B contract pharmacies?

Contact Us for a copy of the recording